Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by qualityassurance – 2020-02-04 12:28 (1936 d 12:36 ago) – Posting: # 21141
Views: 4,793

Hello all,

We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.

Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
32 visitors (0 registered, 32 guests [including 13 identified bots]).
Forum time: 02:04 CEST (Europe/Vienna)

An expert is someone who knows some of the worst mistakes
that can be made in his subject,
and how to avoid them.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5